Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders”

127 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 127 results

Not applicableEnrolling By InvitationNCT05982925
What this trial is testing

Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders

Who this might be right for
Multiple SclerosisNeuromyelitis OpticaDemyelinating Autoimmune Diseases, CNS
Icahn School of Medicine at Mount Sinai 170
Not applicableUnknownNCT05414890
What this trial is testing

Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination

Who this might be right for
NMO Spectrum DisorderNMDA-R EncephalitisDiagnostic Self Evaluation+4 more
Beijing Tiantan Hospital 2,500
Not applicableStudy completedNCT07032337
What this trial is testing

Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Samsung Medical Center 2,985
Not applicableStudy completedNCT04388072
What this trial is testing

An Diagnostic Cohort on AQP4-Immunoglobulin G Detection Kit

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
First Affiliated Hospital of Fujian Medical University 200
Not applicableLooking for participantsNCT04106830
What this trial is testing

Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)

Who this might be right for
NMO Spectrum DisorderMRIMultiple Sclerosis+1 more
Beijing Tiantan Hospital 1,000
Not applicableLooking for participantsNCT05891379
What this trial is testing

Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Xuanwu Hospital, Beijing 50
Not applicableLooking for participantsNCT07377305
What this trial is testing

Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
NMO Spectrum Disorder
Tang-Du Hospital 12
Not applicableEnded earlyNCT04131764
What this trial is testing

Diagnosis of ON With or Without MS or NMOSD

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum Disorder AttackNeuromyelitis Optica Spectrum Disorder Relapse+2 more
Jagannadha R Avasarala 112
Early research (Phase 1)Not Yet RecruitingNCT07573332
What this trial is testing

A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Patients

Who this might be right for
AQP4+ NMOSD
University of Texas Southwestern Medical Center 5
Not applicableStudy completedNCT03942952
What this trial is testing

PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingNeuromyelitis OpticaAcute Disseminated Encephalomyelitis+1 more
University of Texas Southwestern Medical Center 49
Large-scale testing (Phase 3)Ended earlyNCT02398994
What this trial is testing

A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis

Who this might be right for
Myelitis, TransverseNeuromyelitis Optica
Guy's and St Thomas' NHS Foundation Trust 2
Not applicableEnrolling By InvitationNCT07636876
What this trial is testing

The Italian Multiple Sclerosis and Related Disorders Register

Who this might be right for
Multiple SclerosisNeuromyelitis OpticaDemyelinating Diseases of the Central Nervous System+3 more
Fondazione Italiana Sclerosi Multipla 96,000
Testing effectiveness (Phase 2)WithdrawnNCT05909943
What this trial is testing

Efficacy and Safety of Ruxolitinib in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Relapse
Tianjin Medical University General Hospital
Not applicableLooking for participantsNCT03900221
What this trial is testing

French Registry for Monitoring Pregnancies for Multiple Sclerosis

Who this might be right for
Sclerosis, MultipleNeuromyelitis Optica Spectrum DisorderMyelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders+1 more
Hospices Civils de Lyon 1,500
Testing effectiveness (Phase 2)Study completedNCT05154734
What this trial is testing

Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
NMO Spectrum Disorder
Tianjin Medical University General Hospital 14
Large-scale testing (Phase 3)Study completedNCT04660539
What this trial is testing

Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Hoffmann-La Roche 119
Very early researchNot Yet RecruitingNCT07392528
What this trial is testing

Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMultiple SclerosisMyasthenia Gravis
Tianjin Huanhu Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT05504694
What this trial is testing

Ofatumumab in AQP4-IgG Seropositive NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Tang-Du Hospital 5
Early research (Phase 1)Study completedNCT03138421
What this trial is testing

Central Pain Study for ABX-1431

Who this might be right for
Neuromyelitis Optica Spectrum DisorderTransverse MyelitisMultiple Sclerosis+1 more
Abide Therapeutics 9
Not applicableLooking for participantsNCT06865274
What this trial is testing

Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis.

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMOGADMultiple Sclerosis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Load More Results